Clinical Study Data Request Registered Users, Please Login

Scroll down the list of studies provided below. Studies are listed by study medicine in alphabetical order. Alternatively you can browse the list of studies using the search function.

To select studies and submit a research proposal or enquiry, go back to the Home page and select View and submit.

This takes you back to the previous page to enable you to view studies from a different sponsor.

Select medicine, medical condition or phase from the drop down boxes. This searches all the available clinical studies. Selecting from more than one drop down box will “and” the criteria.

Find by:


Alternatively search for studies using the UCB Clinical Study Identification Number or study title by entering text and clicking search.

 

35 found

Click the study title to find more information about the study.

UCB-NO1252
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Medicine: Brivaracetam, Condition: Epilepsy, Phase: 3, Clinical Study ID: NO1252, Sponsor: UCB
UCB-NO1253
Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Medicine: Brivaracetam, Condition: Epilepsy, Phase: 3, Clinical Study ID: NO1253, Sponsor: UCB
UCB-C87031
A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

Medicine: Certolizumab Pegol , Condition: Crohn's Disease, Phase: 3, Clinical Study ID: C87031, Sponsor: UCB
UCB-C87032
Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Medicine: Certolizumab Pegol , Condition: Crohn's Disease, Phase: 3, Clinical Study ID: C87032, Sponsor: UCB
UCB-C87014
Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis

Medicine: Certolizumab Pegol , Condition: Rheumatoid Arthritis, Phase: 3, Clinical Study ID: C87014, Sponsor: UCB
UCB- C87027
A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

Medicine: Certolizumab Pegol , Condition: Rheumatoid Arthritis, Phase: 3, Clinical Study ID: C87027 , Sponsor: UCB.
UCB-C87050
A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Medicine: Certolizumab Pegol , Condition: Rheumatoid Arthritis, Phase: 3, Clinical Study ID: C87050, Sponsor: UCB
UCB-AS0001
Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis

Medicine: Certolizumab Pegol , Condition: Axial Spondyloarthritis , Phase: 3, Clinical Study ID: AS0001, Sponsor: UCB.
UCB-PsA001
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

Medicine: Certolizumab Pegol , Condition: Psoriatic Arthritis, Phase: 3, Clinical Study ID: PsA001, Sponsor: UCB
UCB-C87085
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Medicine: Certolizumab Pegol , Condition: Crohn's Disease, Phase: 3, Clinical Study ID: C87085, Sponsor: UCB
First Previous 1 2 3 4 Next Last